In prostate cancer, comparison of expression between benign prostatic hyperplasia and low- and high-risk primary prostate cancer samples, revealed 56 proteins, including MRPL4, which were highly expressed in the high-risk samples compared to the other two groups [45]. This evidence concerns the gene MRPL4 and Familial prostate cancer.